WEREWOLF THERAPEUTICS INC (HOWL) Stock Analyst Earnings Estimates
NASDAQ:HOWL - Nasdaq - US95075A1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.4M | 19.943M 21.60% | 1.885M -90.55% | -100.00% | 14.769M | 59.744M 304.52% | 104.2M 74.41% | 223.07M 114.08% | 269.18M 20.67% | |||
| EBITDA YoY % growth | -54.96M -10.21% | -38.739M 29.51% | -71.78M -85.29% | -89.362M -24.49% | -97.614M -9.23% | -99.654M -2.09% | -96.186M 3.48% | -71.604M 25.56% | -29.172M 59.26% | N/A | N/A | |
| EBIT YoY % growth | -56.06M -11.92% | -40.503M 27.75% | -73.594M -81.70% | -89.109M -21.08% | -113.708M -27.60% | -138.92M -22.17% | -123.486M 11.11% | -84.91M 31.24% | -21.777M 74.35% | 70.88M 425.48% | 153.34M 116.34% | |
| Operating Margin | -341.83% | -203.09% | -3,904.19% | N/A | N/A | N/A | -836.12% | -142.12% | -20.90% | 31.77% | 56.97% | |
| EPS YoY % growth | -1.88 97.87% | -1.04 44.68% | -1.63 -56.73% | -1.81 -11.01% | -1.80 0.56% | -2.02 -12.10% | -1.75 13.27% | -1.13 35.28% | -0.42 62.61% | 0.53 224.10% | 1.22 133.01% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.49 -22.40% | -0.47 -22.40% | -0.45 2.88% | -0.50 -24.10% | -0.34 30.21% | -0.37 20.83% | -0.40 11.42% | -0.44 11.23% | -0.43 -25.67% | -0.49 -33.24% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | -18.88M -4.65% | -19.655M -24.78% | -20.502M -10.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.112M -21.90% | -23.436M -36.86% | -23.779M -16.86% | -19.304M -7.30% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.40 -2.56% | -0.40 | 0.00 | 0.47% |
| Q4 2024 Q2Q % growth | -0.46 -39.39% | -0.43 | -0.03 | -7.80% |
| Q3 2024 Q2Q % growth | -0.38 -65.22% | -0.42 | 0.04 | 9.61% |
| Q2 2024 Q2Q % growth | -0.40 -185.71% | -0.38 | -0.02 | -4.30% |
| Q1 2024 Q2Q % growth | -0.39 -14.71% | -0.36 | -0.03 | -9.56% |
| Q4 2023 Q2Q % growth | -0.33 15.38% | -0.44 | 0.11 | 25.39% |
| Q3 2023 Q2Q % growth | -0.23 42.50% | -0.40 | 0.17 | 42.88% |
| Q2 2023 Q2Q % growth | -0.14 73.58% | -0.43 | 0.29 | 67.48% |
| Q1 2023 Q2Q % growth | -0.34 39.29% | -0.51 | 0.17 | 33.33% |
| Q4 2022 Q2Q % growth | -0.39 40.91% | -0.56 | 0.17 | 29.97% |
| Q3 2022 Q2Q % growth | -0.40 21.57% | -0.61 | 0.21 | 34.91% |
| Q2 2022 Q2Q % growth | -0.53 86.13% | -0.44 | -0.09 | -21.55% |
| Q1 2022 Q2Q % growth | -0.56 99.33% | -0.63 | 0.07 | 10.73% |
| Q4 2021 Q2Q % growth | -0.66 | -0.54 | -0.12 | -22.09% |
| Q3 2021 Q2Q % growth | -0.51 | -0.45 | -0.06 | -12.36% |
| Q2 2021 Q2Q % growth | -3.82 | -0.37 | -3.45 | -921.38% |
| Q1 2021 Q2Q % growth | -83.36 | -0.47 | -82.89 | -17,666.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | 306K | -306K | -100.00% |
| Q4 2024 Q2Q % growth | -100.00% | 307.703K | -307.703K | -100.00% |
| Q3 2024 Q2Q % growth | -100.00% | 724.2K | -724.2K | -100.00% |
| Q2 2024 Q2Q % growth | 1.143M -85.86% | 858.84K | 284.16K | 33.09% |
| Q1 2024 Q2Q % growth | 742K -83.38% | 1.859M | -1.117M | -60.09% |
| Q4 2023 Q2Q % growth | 1.501M -79.38% | 1.983M | -482K | -24.31% |
| Q3 2023 Q2Q % growth | 5.897M 18.65% | 1.624M | 4.273M | 263.12% |
| Q2 2023 Q2Q % growth | 8.081M 94.72% | 2.512M | 5.569M | 221.70% |
| Q1 2023 Q2Q % growth | 4.464M | 5.1M | -636K | -12.47% |
| Q4 2022 Q2Q % growth | 7.28M | 2.114M | 5.166M | 244.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.08% | 0% | -0.57% |
| Revenue | N/A | -100% | N/A | -100% |